切片檢查活體組織切片市場報告：趨勢、預測和競爭分析（至2035年）

全球切片檢查市場前景廣闊，醫院和診所預計將迎來大量機會。預計2026年至2035年，全球切片檢查市場將以7.9%的複合年成長率成長，到2035年市場規模預計將達到12.85億美元。推動該市場成長的關鍵因素包括：對微創診斷的需求不斷成長、癌症和腫瘤發病率上升，以及醫院和診所對活體組織切片技術的日益普及。

• 根據 Lucintel 的預測，全自動化產品在預測期內有望呈現更高的成長率。
• 從應用領域來看，醫院產業預計將呈現最高的成長率。
• 從區域來看，亞太地區預計在預測期內將呈現最高的成長率。

切片檢查市場的新趨勢

受技術進步、微創手術需求成長以及對提高診斷準確性的重視等因素驅動，切片檢查市場正在快速發展。隨著醫療服務提供者尋求更有效率、更安全、更人性化的方案，市場上湧現許多創新產品和技術。這些進步不僅改善了臨床療效，也拓展了切片檢查手術在各醫學專科的應用範圍。以下關鍵趨勢突顯了正在塑造該市場的變革性變化，反映了精準醫療、技術整合和以患者為中心的醫療模式的轉變。

• 技術創新與智慧切片檢查設備：機器人輔助成像、即時影像處理和自動化等先進技術的融合正在革新切片檢查。這些智慧型設備能夠提高活體組織切片的準確性、縮短手術時間並增強安全性。諸如電動可程式設計切片檢查等創新技術使臨床醫生能夠獲得更精確的組織樣本，尤其是在解剖結構複雜的部位。推動這些設備應用的動力源自於對微創、高效和可靠的切片檢查技術的需求，最終將帶來更好的診斷效果和更高的患者滿意度。
• 微創技術的廣泛應用：隨著患者尋求疼痛更少、恢復更快的治療方案，微創切片檢查技術正成為主流。專為這些手術設計的切片檢查設備也日趨精密，採用更細的針頭，操作也更方便。這一趨勢在腫瘤學領域尤其顯著，因為早期發現至關重要。微創技術的引入減少了併發症、縮短了住院時間，並降低了整體醫療成本，使其成為醫護人員和病患的首選。
• 腫瘤學和介入放射學領域的應用不斷拓展：切片檢查的需求已從傳統的乳房和皮膚切片檢查等應用擴展到複雜的腫瘤學和介入放射學手術。先進的切片檢查現在可以靶向位於組織深處的腫瘤，並獲取高品質的組織樣本進行分子分析。這種應用拓展是由癌症發生率的上升以及對精準診斷和個人化治療方案的需求所驅動的。因此，製造商正在開發針對特定臨床應用的專用切片檢查，從而擴大了市場範圍。
• 安全性和無菌性日益受到重視：確保病患安全和在切片檢查過程中保持無菌是首要任務。市場上正在研發一次性切片檢查，以降低交叉感染的風險。此外，符合人體工學的設計、安全鎖和易於清潔的組件等功能也逐漸成為標準配備。這些創新有助於最大限度地降低感染風險，提高手術安全性，並符合嚴格的醫療法規。這種對安全的重視對於贏得臨床醫生的信任以及在各種醫療機構中推廣使用切片檢查至關重要。
• 攜帶式手持設備需求激增：攜帶式手持切片檢查市場需求激增，這類設備柔軟性易用，適用於包括門診和偏遠地區在內的各種臨床環境。這些設備輕巧便攜，採用電池供電，設計便於快速設置，是床邊診斷的理想選擇。其便攜性提高了醫療資源匱乏地區進行切片檢查的便利性，並能實現快速診斷，尤其是在緊急情況下。這一趨勢與醫療保健分散化的大趨勢相符，有助於改善患者就醫途徑，並減輕大規模醫療機構的負擔。

這些趨勢正在重塑整個切片檢查市場，促進創新，拓展臨床應用，並優先考慮安全性和便利性。這推動了更精準、更人性化、更通用的切片檢查解決方案的普及，最終將提升全球醫療系統的診斷準確性和患者療效。

切片檢查市場的最新趨勢

受技術創新、微創手術需求成長以及醫療保健領域應用範圍不斷擴大的推動，切片檢查市場正經歷快速成長。這些進步正在提升診斷準確性、患者舒適度和手術效率。隨著醫療機構尋求更有效的工具，以及投資增加和監管核准的推進，該市場有望實現顯著成長。對於希望掌握新興趨勢並改善患者預後的利害關係人相關人員，了解這些關鍵機會至關重要。

• 切片檢查的技術創新：更高的精準度和安全性正在革新切片檢查流程。新型號融合了與先進成像技術的兼容性、自動化功能和符合人體工學的設計，從而縮短了手術時間並提高了檢體品質。這些創新增強了臨床醫生的信心，拓展了在複雜病例中的應用，並吸引了投資。因此，市場對高科技切片檢查的需求激增，推動了競爭性成長，並刺激了持續的研發活動。
• 微創手術的廣泛應用：向微創診斷的轉變正在推動切片檢查的銷售。由於患者傾向於選擇疼痛更少、恢復更快的治療方案，醫療機構也擴大採用先進的切片檢查工具。這一趨勢在腫瘤科、乳房科和肝病科的診斷中尤其明顯。微創手術的普及提高了診斷準確性，減少了併發症，並縮短了住院時間。因此，市場受益於手術數量的增加和應用範圍的擴大，從而推動了整個行業的成長。
• 腫瘤學及其他領域的應用拓展：癌症切片檢查的應用範圍正日益擴展，超越了其傳統範疇，尤其是在腫瘤學、循環系統和肌肉骨骼診斷領域。這種應用範圍的擴大使得癌症的早期發現和個人化治療方案的發展成為可能。這種多樣化的應用推動了對不同組織和成像技術而設計的專用切片檢查設備的需求。隨著臨床證據證實其有效性，市場正透過新產品的推出和該技術在多個醫學領域的日益普及而不斷成長。
• 監管核准與市場拓展：監管機構正在核准安全性和有效性均有所提升的創新切片檢查。這些核准有助於產品進入市場，並增強臨床醫生的信心。此外，由於醫療基礎設施的改善和公眾意識的提高，新興市場對活體組織切片槍的接受度也不斷提高。戰略合作與投資進一步加速了市場擴張。這種法規環境正在促進創新，擴大地域覆蓋範圍，增強競爭格局，並最終推動產業的永續發展。
• 數位技術和數據整合的影響：人工智慧和數據分析等數位技術的整合正在提升切片檢查的功能。即時影像導引、自動化檢體分析和資料管理提高了手術的準確性和工作流程的效率。這些進步使得個人化診斷和更佳的患者管理成為可能。智慧切片檢查設備的日益普及正在推動市場創新並創造新的收入來源，市場也因此受益。數位整合將重新定義行業標準並拓展切片檢查手術的範圍。

近年來，切片檢查市場的發展正透過提高診斷準確性、拓展應用領域和加速技術創新，顯著改變產業格局。這些機會正在推動市場成長、吸引投資並改善患者照護。因此，該行業呈現出持續擴張的跡象，不斷增強的競爭力和持續進步正在塑造其未來的發展軌跡。

目錄

第1章執行摘要

第2章 市場概覽

• 背景與分類
• 供應鏈

第3章 市場趨勢與預測分析

• 宏觀經濟趨勢與預測
• 產業促進因素與挑戰
• PESTLE分析
• 專利分析
• 法規環境

第4章 全球癌症切片檢查市場：按類型分類

• 吸引力分析：按類型
• 全自動
• 半自動

第5章：全球癌症切片檢查市場：按應用領域分類

• 吸引力分析：依目的
• 醫院
• 診所
• 其他

第6章 區域分析

第7章：北美切片檢查切片市場

• 北美切片檢查市場：按類型分類
• 北美切片檢查市場：按應用領域分類
• 美國切片檢查市場
• 加拿大切片檢查市場
• 墨西哥切片檢查市場

第8章：歐洲切片檢查市場

• 歐洲癌症切片檢查市場：按類型分類
• 歐洲癌症切片檢查市場：按應用領域分類
• 德國切片檢查市場
• 法國切片檢查市場
• 義大利切片檢查市場
• 西班牙切片檢查市場
• 英國切片檢查市場

第9章：亞太地區癌症切片檢查市場

• 亞太地區癌症切片檢查市場：按類型分類
• 亞太地區癌症切片檢查市場：按應用領域分類
• 中國切片檢查市場
• 印度切片檢查市場
• 日本癌症切片檢查樣本市場
• 韓國切片檢查市場
• 印尼切片檢查市場

第10章：世界各地的切片檢查槍市場

• 其他地區切片檢查槍市場：按類型分類
• 其他地區切片檢查槍市場：按應用領域分類
• 中東切片檢查市場
• 南非癌症切片檢查市場
• 非洲切片檢查市場

第11章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析
• 市佔率分析

第12章 機會與策略分析

• 價值鏈分析
• 成長機會分析
• 新趨勢：全球癌症切片檢查市場
• 戰略分析

第13章：價值鏈中主要企業的公司概況

• 競爭分析概述
• Roussel Delma Pharmaceuticals
• Advin Health Care
• Biomedical
• Cathwide Medical
• HEGA-Medical
• Histo
• Medax
• Moeller Medical
• Prosimed
• Slaughter Supply

第14章附錄

The future of the global biopsy gun market looks promising with opportunities in the hospital and clinic markets. The global biopsy gun market is expected to reach an estimated $1,285 million by 2035 with a CAGR of 7.9% from 2026 to 2035. The major drivers for this market are the increasing demand for minimally invasive diagnostics, the rising prevalence of cancer & tumors, and the growing adoption in hospitals & clinics.

• Lucintel forecasts that, within the type category, fully automatic is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Biopsy Gun Market

The biopsy gun market is experiencing rapid evolution driven by technological advancements, increasing demand for minimally invasive procedures, and a focus on improving diagnostic accuracy. As healthcare providers seek more efficient, safe, and patient-friendly options, the market is witnessing the emergence of innovative products and practices. These developments are not only enhancing clinical outcomes but also expanding the scope of biopsy procedures across various medical specialties. The following key trends highlight the transformative changes shaping this market, reflecting a shift towards precision medicine, technological integration, and patient-centric care.

• Technological Innovation and Smart Biopsy Devices: The integration of advanced technologies such as robotic assistance, real-time imaging, and automation is revolutionizing biopsy guns. These smart devices offer enhanced precision, reduced procedure time, and improved safety profiles. Innovations like motorized and programmable biopsy guns enable clinicians to perform more accurate tissue sampling, especially in challenging anatomical locations. The adoption of these devices is driven by the need for minimally invasive, efficient, and reliable biopsy procedures, ultimately leading to better diagnostic outcomes and patient satisfaction.
• Growing Adoption of Minimally Invasive Procedures: There is a significant shift towards minimally invasive biopsy techniques, driven by patient preference for less painful and quicker recovery options. Biopsy guns designed for such procedures are becoming more sophisticated, offering features like smaller gauge needles and enhanced maneuverability. This trend is particularly prominent in oncology, where early detection is critical. The adoption of minimally invasive methods reduces complications, hospital stays, and overall healthcare costs, making them a preferred choice among healthcare providers and patients alike.
• Expansion in Oncology and Interventional Radiology Applications: The demand for biopsy guns is expanding beyond traditional use in breast and skin biopsies to include complex oncological and interventional radiology procedures. Advanced biopsy guns are now capable of targeting deep-seated tumors and providing high-quality tissue samples for molecular analysis. This expansion is driven by the rising prevalence of cancer and the need for precise diagnosis and personalized treatment plans. As a result, manufacturers are developing specialized biopsy guns tailored for specific clinical applications, broadening the market scope.
• Increasing Focus on Safety and Sterility: Ensuring patient safety and maintaining sterility during biopsy procedures are paramount. The market is witnessing the development of disposable, single-use biopsy guns that reduce cross-contamination risks. Additionally, features like ergonomic designs, safety locks, and easy-to-clean components are becoming standard. These innovations help minimize infection risks, improve procedural safety, and comply with stringent healthcare regulations. The emphasis on safety is crucial in gaining clinician confidence and expanding the adoption of biopsy guns across diverse healthcare settings.
• Rising Demand for Portable and Handheld Devices: The market is witnessing a surge in portable, handheld biopsy guns that offer flexibility and ease of use in various clinical environments, including outpatient clinics and remote locations. These devices are lightweight, battery-operated, and designed for quick setup, making them ideal for point-of-care diagnostics. The portability enhances access to biopsy procedures in underserved areas and facilitates rapid diagnosis, especially in emergency settings. This trend aligns with the broader shift towards decentralized healthcare, improving patient access and reducing the burden on large medical facilities.

These trends are collectively reshaping the biopsy gun market by fostering innovation, expanding clinical applications, and emphasizing safety and convenience. They are driving the adoption of more precise, patient-friendly, and versatile biopsy solutions, ultimately improving diagnostic accuracy and patient outcomes across healthcare systems worldwide.

Recent Developments in the Biopsy Gun Market

The biopsy gun market is experiencing rapid advancements driven by technological innovations, increasing demand for minimally invasive procedures, and expanding applications across medical fields. These developments are transforming diagnostic accuracy, patient comfort, and procedural efficiency. As healthcare providers seek more effective tools, the market is poised for significant growth, supported by rising investments and regulatory approvals. Understanding these key opportunities is essential for stakeholders aiming to capitalize on emerging trends and improve patient outcomes.

• Technological Innovations in Biopsy Guns: Enhanced precision and safety features are revolutionizing biopsy procedures. New models incorporate advanced imaging compatibility, automated functions, and ergonomic designs, reducing procedure time and improving sample quality. These innovations increase clinician confidence, expand usage in complex cases, and attract investments. As a result, the market is witnessing a surge in demand for high-tech biopsy guns, fostering competitive growth and encouraging ongoing R&D efforts.
• Rising Adoption of Minimally Invasive Procedures: The shift towards minimally invasive diagnostics is boosting biopsy gun sales. Patients prefer less painful, quicker recovery options, prompting healthcare providers to adopt advanced biopsy tools. This trend is especially prominent in oncology, breast, and liver diagnostics. The increased adoption enhances diagnostic accuracy, reduces complications, and shortens hospital stays. Consequently, the market benefits from higher procedural volumes and broader application scopes, fueling overall industry expansion.
• Growing Applications in Oncology and Other Fields: Biopsy guns are increasingly used beyond traditional applications, notably in oncology, cardiology, and musculoskeletal diagnostics. The expanding scope allows for early detection and personalized treatment planning. This diversification drives demand for specialized biopsy devices tailored to different tissues and imaging techniques. As clinical evidence supports their efficacy, the market experiences growth through new product launches and increased procedural adoption across multiple medical disciplines.
• Regulatory Approvals and Market Expansion: Regulatory bodies are approving innovative biopsy guns with improved safety and efficacy profiles. These approvals facilitate market entry and boost clinician confidence. Additionally, emerging markets are witnessing increased adoption due to rising healthcare infrastructure and awareness. Strategic collaborations and investments are further accelerating market expansion. This regulatory environment fosters innovation, broadens geographic reach, and enhances competitive dynamics, ultimately contributing to sustained industry growth.
• Impact of Digital and Data Integration: Integration of digital technologies, such as AI and data analytics, is enhancing biopsy gun functionality. Real-time imaging guidance, automated sample analysis, and data management improve procedural accuracy and workflow efficiency. These advancements enable personalized diagnostics and better patient management. The market benefits from increased adoption of smart biopsy devices, fostering innovation and creating new revenue streams. Digital integration is set to redefine industry standards and expand the scope of biopsy procedures.

The recent developments in the biopsy gun market are significantly transforming the industry landscape by improving diagnostic precision, expanding application areas, and fostering technological innovation. These opportunities are driving market growth, attracting investments, and enhancing patient care. As a result, the industry is poised for sustained expansion, with increased competitiveness and ongoing advancements shaping its future trajectory.

Strategic Growth Opportunities in the Biopsy Gun Market

The biopsy gun market is experiencing significant growth driven by advancements in medical technology, the increasing prevalence of cancer, and the demand for minimally invasive diagnostic procedures. Rising awareness about early detection and improved healthcare infrastructure further contributes to expanding opportunities. Manufacturers are focusing on innovation, safety, and precision to meet the evolving needs of healthcare providers and patients. This dynamic environment presents numerous avenues for strategic expansion and technological development, promising substantial market growth in the coming years.

• Increasing Adoption of Minimally Invasive Procedures: The rising preference for minimally invasive biopsy techniques is a key growth driver. Biopsy guns offer precise, less painful, and quicker procedures, reducing patient recovery time. As healthcare providers aim to improve patient outcomes and reduce hospital stays, demand for advanced biopsy guns is surging. Technological innovations that enhance accuracy and safety are further fueling adoption across hospitals, clinics, and specialized diagnostic centers worldwide.
• Rising Incidence of Cancer and Chronic Diseases: The growing prevalence of cancer and other chronic diseases globally is significantly boosting the need for early diagnosis. Biopsy guns are essential tools for obtaining tissue samples for accurate diagnosis and treatment planning. Increased screening programs and awareness campaigns are leading to higher detection rates, thereby expanding the market. This trend underscores the importance of reliable biopsy devices to support timely and effective medical interventions.
• Technological Innovations in Biopsy Devices: Continuous advancements in biopsy gun technology, such as automation, improved ergonomics, and enhanced imaging compatibility, are creating new growth opportunities. These innovations increase procedural precision, reduce complications, and improve patient comfort. Companies investing in R&D to develop smarter, more efficient devices are gaining competitive advantages. The integration of digital and imaging technologies is expected to further revolutionize biopsy procedures, expanding market reach and application scope.
• Growing Healthcare Infrastructure in Emerging Markets: Emerging economies are witnessing rapid healthcare infrastructure development, increasing access to diagnostic services. This expansion creates a substantial market for biopsy guns, especially in rural and underserved areas. Government initiatives, investments, and partnerships are facilitating the adoption of advanced medical devices. As healthcare systems strengthen, demand for reliable, cost-effective biopsy solutions is expected to rise, opening new avenues for market players to expand their presence.
• Increasing Focus on Safety and Sterility Standards: The emphasis on patient safety and infection control is prompting manufacturers to develop biopsy guns with enhanced safety features. Innovations such as disposable components, safety locks, and sterilization compatibility are gaining importance. Regulatory standards are becoming more stringent, encouraging product improvements. This focus on safety not only reduces procedural risks but also boosts clinician confidence, thereby driving market growth through increased adoption of safer, compliant biopsy devices.

The overall impact of these opportunities is set to significantly accelerate market growth, fostering innovation and expanding access to advanced diagnostic tools. As technological, infrastructural, and safety considerations evolve, the biopsy gun market is poised for sustained expansion, ultimately improving diagnostic accuracy and patient outcomes worldwide.

Biopsy Gun Market Driver and Challenges

The biopsy gun market is influenced by a variety of technological, economic, and regulatory factors that shape its growth and development. Advances in medical technology, increasing demand for minimally invasive procedures, and evolving regulatory standards are key drivers. Economic factors such as rising healthcare expenditure and the growing prevalence of chronic diseases further propel market expansion. However, the market also faces challenges, including high costs, regulatory hurdles, and concerns over procedural safety. Understanding these drivers and challenges is essential for stakeholders to navigate the dynamic landscape effectively and capitalize on emerging opportunities.

The factors responsible for driving the biopsy gun market include:-

• Technological Innovation: The continuous development of advanced biopsy guns with improved precision, safety features, and ease of use significantly enhances clinical outcomes. Innovations such as automated and imaging-guided biopsy guns enable more accurate tissue sampling, reducing procedure time and patient discomfort. These technological advancements attract healthcare providers seeking efficient diagnostic tools, thereby expanding market adoption. Moreover, integration with digital health systems and AI-driven guidance further boosts the market by offering enhanced diagnostic accuracy and workflow efficiency, making biopsy procedures more reliable and accessible.
• Rising Prevalence of Chronic Diseases: The increasing incidence of cancer, infectious diseases, and other chronic conditions worldwide is a major driver. As these diseases often require tissue diagnosis for effective treatment planning, the demand for biopsy procedures rises. The growing aging population, which is more susceptible to such diseases, further amplifies this need. Consequently, healthcare providers are investing in advanced biopsy guns to meet the rising diagnostic demand, fueling market growth. This trend is particularly prominent in developing regions where healthcare infrastructure is expanding rapidly to accommodate the increasing disease burden.
• Growing Preference for Minimally Invasive Procedures: Patients and clinicians favor minimally invasive diagnostic options due to reduced pain, shorter recovery times, and lower complication rates. Biopsy guns facilitate such procedures, making them a preferred choice over traditional surgical biopsies. The shift towards outpatient and office-based procedures also drives demand for portable, easy-to-use biopsy devices. This preference encourages manufacturers to innovate and improve biopsy gun designs, thereby expanding their market share. Additionally, insurance providers are more likely to cover minimally invasive procedures, further incentivizing their adoption and supporting market growth.
• Increasing Healthcare Expenditure and Investment: Rising healthcare budgets and investments in diagnostic infrastructure are fueling the market. Governments and private entities are allocating funds to improve diagnostic capabilities, including the procurement of advanced biopsy guns. This financial support enables healthcare facilities to upgrade their equipment, adopt new technologies, and expand diagnostic services. The increasing affordability of high-quality biopsy devices due to technological advancements also makes them accessible to a broader range of healthcare providers, especially in emerging markets, thus broadening the market scope.
• Expansion of Diagnostic and Interventional Procedures: The expanding scope of diagnostic and interventional radiology procedures is a significant driver. Biopsy guns are integral to various minimally invasive interventions, including tumor biopsies, lymph node sampling, and organ-specific tissue collection. As medical practitioners increasingly adopt these procedures for early diagnosis and treatment monitoring, the demand for reliable biopsy guns grows. The development of specialized biopsy devices tailored for different anatomical sites and clinical needs further stimulates market expansion, supporting better patient outcomes and procedural efficiency.

The challenges facing the biopsy gun market include:-

• High Cost of Advanced Biopsy Guns: Despite technological advancements, the high cost of sophisticated biopsy guns remains a barrier, especially in developing regions. These devices often require significant investment, which can limit adoption among smaller healthcare providers and in resource-constrained settings. Additionally, the cost of maintenance, disposables, and training adds to the overall expenditure, impacting the affordability and widespread use of these devices. This financial barrier can slow market growth and restrict access to cutting-edge diagnostic tools, thereby affecting overall market penetration.
• Regulatory and Approval Hurdles: Stringent regulatory standards and lengthy approval processes pose significant challenges. Biopsy guns must meet rigorous safety, efficacy, and quality standards set by health authorities such as the FDA or EMA. Navigating these regulatory pathways can delay product launches and increase costs for manufacturers. Moreover, evolving regulations and compliance requirements necessitate continuous updates and testing, which can hinder innovation and market entry, especially for smaller or emerging companies. These hurdles can slow down the availability of new and improved biopsy devices in the market.
• Safety and Procedural Risks: Concerns over procedural safety, including risks of infection, bleeding, and tissue damage, impact market growth. Ensuring patient safety requires rigorous training and adherence to protocols, which can be challenging in busy clinical settings. Additionally, complications arising from improper use or device malfunction can lead to legal liabilities and reputational damage for manufacturers. Addressing these safety concerns involves ongoing research, improved device design, and comprehensive training programs, which can increase costs and complexity for providers and manufacturers alike.

The biopsy gun market is driven by technological innovations, rising disease prevalence, and a shift towards minimally invasive procedures, all supported by increasing healthcare investments. However, high costs, regulatory challenges, and safety concerns pose significant hurdles. These factors collectively influence market dynamics, with opportunities for growth in emerging regions and specialized applications. Navigating these drivers and challenges will be crucial for stakeholders aiming to expand their market presence and improve diagnostic outcomes. Overall, the markets future depends on balancing innovation with safety, affordability, and regulatory compliance to meet the evolving needs of healthcare providers and patients worldwide.

List of Biopsy Gun Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopsy gun companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopsy gun companies profiled in this report include-

• Roussel Delma Pharmaceuticals
• Advin Health Care
• Biomedical
• Cathwide Medical
• HEGA-Medical
• Histo
• Medax
• Moeller Medical
• Prosimed
• Slaughter Supply

Biopsy Gun Market by Segment

The study includes a forecast for the global biopsy gun market by type, application, and region.

Biopsy Gun Market by Type [Value from 2019 to 2035]:

• Fully Automatic
• Semi-Automatic

Biopsy Gun Market by Application [Value from 2019 to 2035]:

• Hospitals
• Clinics
• Others

Biopsy Gun Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biopsy Gun Market

The biopsy gun market has experienced significant advancements driven by technological innovations, increasing demand for minimally invasive procedures, and expanding healthcare infrastructure worldwide. Countries are adopting new devices that improve accuracy, safety, and patient comfort. Regulatory approvals and rising investments in medical research further propel market growth. The evolving landscape reflects a focus on precision medicine and personalized treatment options, with key players continuously innovating to meet the needs of diverse healthcare settings. These developments are shaping the future of diagnostic and therapeutic procedures, making biopsy guns more efficient, user-friendly, and accessible across different regions.

• United States: The US market has seen rapid adoption of advanced biopsy guns with enhanced imaging compatibility and ergonomic designs. Innovations include automated and semi-automated devices that improve precision and reduce procedure time. Regulatory approvals for new products have increased, supported by strong healthcare infrastructure and high healthcare expenditure. The rise in minimally invasive procedures and growing awareness about early diagnosis have further fueled market growth. Additionally, collaborations between medical device companies and research institutions are fostering innovation, leading to the development of smarter, more efficient biopsy guns tailored for various clinical applications.
• China: China's biopsy gun market is expanding due to increasing healthcare investments and a rising prevalence of chronic diseases requiring early diagnosis. Local manufacturers are gaining prominence by offering cost-effective, technologically advanced devices that meet domestic demand. The government's focus on healthcare reform and infrastructure development has improved access to diagnostic procedures. Moreover, the adoption of minimally invasive techniques is growing, supported by rising awareness among healthcare professionals. International companies are entering the Chinese market through partnerships and joint ventures, boosting innovation and product availability. The market is expected to continue its rapid growth trajectory driven by technological adoption and expanding healthcare coverage.
• Germany: Germany's market is characterized by high-quality, precision biopsy guns used predominantly in specialized medical centers. The focus on patient safety and comfort has led to innovations in device design, including improved needle stability and imaging integration. Stringent regulatory standards ensure high product quality and safety. The increasing prevalence of cancer and other chronic diseases has driven demand for accurate biopsy tools. Germany's strong healthcare system and emphasis on research and development foster continuous innovation. Additionally, collaborations between academia and industry are leading to the development of advanced biopsy devices that cater to complex diagnostic needs, maintaining Germany's position as a leader in medical technology.
• India: The Indian biopsy gun market is witnessing rapid growth due to rising healthcare awareness, increasing prevalence of cancer, and expanding healthcare infrastructure. Cost-effective, portable, and easy-to-use devices are in high demand, especially in rural and semi-urban areas. Government initiatives to improve healthcare access and the growth of private healthcare providers are further boosting market expansion. Local manufacturers are innovating to produce affordable devices that meet international standards. The adoption of minimally invasive procedures is increasing, supported by a growing number of trained healthcare professionals. Overall, the market is poised for significant growth driven by technological adoption and increasing healthcare expenditure.
• Japan: Japan's market is characterized by high adoption of advanced biopsy guns with integrated imaging capabilities and enhanced safety features. The focus on precision medicine and early diagnosis has led to innovations in device technology. The aging population has increased the demand for minimally invasive and outpatient procedures, prompting manufacturers to develop user-friendly and efficient devices. Strict regulatory standards ensure high product safety and quality. Japan's strong healthcare infrastructure and emphasis on research and development foster continuous innovation. Collaborations between industry and academia are advancing the development of sophisticated biopsy tools, maintaining Japan's leadership in medical technology and innovation.

Features of the Global Biopsy Gun Market

• Market Size Estimates: Biopsy gun market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: Biopsy gun market size by type, application, and region in terms of value ($M).
• Regional Analysis: Biopsy gun market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the biopsy gun market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopsy gun market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopsy gun market by type (fully automatic and semi-automatic), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Biopsy Gun Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Fully Automatic : Trends and Forecast (2019-2035)
• 4.4 Semi-Automatic : Trends and Forecast (2019-2035)

5. Global Biopsy Gun Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospitals : Trends and Forecast (2019-2035)
• 5.4 Clinics : Trends and Forecast (2019-2035)
• 5.5 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Biopsy Gun Market by Region

7. North American Biopsy Gun Market

• 7.1 Overview
• 7.2 North American Biopsy Gun Market by Type
• 7.3 North American Biopsy Gun Market by Application
• 7.4 The United States Biopsy Gun Market
• 7.5 Canadian Biopsy Gun Market
• 7.6 Mexican Biopsy Gun Market

8. European Biopsy Gun Market

• 8.1 Overview
• 8.2 European Biopsy Gun Market by Type
• 8.3 European Biopsy Gun Market by Application
• 8.4 German Biopsy Gun Market
• 8.5 French Biopsy Gun Market
• 8.6 Italian Biopsy Gun Market
• 8.7 Spanish Biopsy Gun Market
• 8.8 The United Kingdom Biopsy Gun Market

9. APAC Biopsy Gun Market

• 9.1 Overview
• 9.2 APAC Biopsy Gun Market by Type
• 9.3 APAC Biopsy Gun Market by Application
• 9.4 Chinese Biopsy Gun Market
• 9.5 Indian Biopsy Gun Market
• 9.6 Japanese Biopsy Gun Market
• 9.7 South Korean Biopsy Gun Market
• 9.8 Indonesian Biopsy Gun Market

10. ROW Biopsy Gun Market

• 10.1 Overview
• 10.2 ROW Biopsy Gun Market by Type
• 10.3 ROW Biopsy Gun Market by Application
• 10.4 Middle Eastern Biopsy Gun Market
• 10.5 South American Biopsy Gun Market
• 10.6 African Biopsy Gun Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global Biopsy Gun Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Roussel Delma Pharmaceuticals
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Advin Health Care
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Biomedical
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Cathwide Medical
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 HEGA-Medical
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Histo
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Medax
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Moeller Medical
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Prosimed
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Slaughter Supply
  • Company Overview
  • Biopsy Gun Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global Biopsy Gun Market
• Figure 2.1: Usage of Biopsy Gun Market
• Figure 2.2: Classification of the Global Biopsy Gun Market
• Figure 2.3: Supply Chain of the Global Biopsy Gun Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 3.19: Driver and Challenges of the Biopsy Gun Market
• Figure 4.1: Global Biopsy Gun Market by Type in 2019, 2025, and 2035
• Figure 4.2: Trends of the Global Biopsy Gun Market ($M) by Type
• Figure 4.3: Forecast for the Global Biopsy Gun Market ($M) by Type
• Figure 4.4: Trends and Forecast for Fully Automatic in the Global Biopsy Gun Market (2019-2035)
• Figure 4.5: Trends and Forecast for Semi-Automatic in the Global Biopsy Gun Market (2019-2035)
• Figure 5.1: Global Biopsy Gun Market by Application in 2019, 2025, and 2035
• Figure 5.2: Trends of the Global Biopsy Gun Market ($M) by Application
• Figure 5.3: Forecast for the Global Biopsy Gun Market ($M) by Application
• Figure 5.4: Trends and Forecast for Hospitals in the Global Biopsy Gun Market (2019-2035)
• Figure 5.5: Trends and Forecast for Clinics in the Global Biopsy Gun Market (2019-2035)
• Figure 5.6: Trends and Forecast for Others in the Global Biopsy Gun Market (2019-2035)
• Figure 6.1: Trends of the Global Biopsy Gun Market ($M) by Region (2019-2025)
• Figure 6.2: Forecast for the Global Biopsy Gun Market ($M) by Region (2026-2035)
• Figure 7.1: Trends and Forecast for the North American Biopsy Gun Market (2019-2035)
• Figure 7.2: North American Biopsy Gun Market by Type in 2019, 2025, and 2035
• Figure 7.3: Trends of the North American Biopsy Gun Market ($M) by Type (2019-2025)
• Figure 7.4: Forecast for the North American Biopsy Gun Market ($M) by Type (2026-2035)
• Figure 7.5: North American Biopsy Gun Market by Application in 2019, 2025, and 2035
• Figure 7.6: Trends of the North American Biopsy Gun Market ($M) by Application (2019-2025)
• Figure 7.7: Forecast for the North American Biopsy Gun Market ($M) by Application (2026-2035)
• Figure 7.8: Trends and Forecast for the United States Biopsy Gun Market ($M) (2019-2035)
• Figure 7.9: Trends and Forecast for the Mexican Biopsy Gun Market ($M) (2019-2035)
• Figure 7.10: Trends and Forecast for the Canadian Biopsy Gun Market ($M) (2019-2035)
• Figure 8.1: Trends and Forecast for the European Biopsy Gun Market (2019-2035)
• Figure 8.2: European Biopsy Gun Market by Type in 2019, 2025, and 2035
• Figure 8.3: Trends of the European Biopsy Gun Market ($M) by Type (2019-2025)
• Figure 8.4: Forecast for the European Biopsy Gun Market ($M) by Type (2026-2035)
• Figure 8.5: European Biopsy Gun Market by Application in 2019, 2025, and 2035
• Figure 8.6: Trends of the European Biopsy Gun Market ($M) by Application (2019-2025)
• Figure 8.7: Forecast for the European Biopsy Gun Market ($M) by Application (2026-2035)
• Figure 8.8: Trends and Forecast for the German Biopsy Gun Market ($M) (2019-2035)
• Figure 8.9: Trends and Forecast for the French Biopsy Gun Market ($M) (2019-2035)
• Figure 8.10: Trends and Forecast for the Spanish Biopsy Gun Market ($M) (2019-2035)
• Figure 8.11: Trends and Forecast for the Italian Biopsy Gun Market ($M) (2019-2035)
• Figure 8.12: Trends and Forecast for the United Kingdom Biopsy Gun Market ($M) (2019-2035)
• Figure 9.1: Trends and Forecast for the APAC Biopsy Gun Market (2019-2035)
• Figure 9.2: APAC Biopsy Gun Market by Type in 2019, 2025, and 2035
• Figure 9.3: Trends of the APAC Biopsy Gun Market ($M) by Type (2019-2025)
• Figure 9.4: Forecast for the APAC Biopsy Gun Market ($M) by Type (2026-2035)
• Figure 9.5: APAC Biopsy Gun Market by Application in 2019, 2025, and 2035
• Figure 9.6: Trends of the APAC Biopsy Gun Market ($M) by Application (2019-2025)
• Figure 9.7: Forecast for the APAC Biopsy Gun Market ($M) by Application (2026-2035)
• Figure 9.8: Trends and Forecast for the Japanese Biopsy Gun Market ($M) (2019-2035)
• Figure 9.9: Trends and Forecast for the Indian Biopsy Gun Market ($M) (2019-2035)
• Figure 9.10: Trends and Forecast for the Chinese Biopsy Gun Market ($M) (2019-2035)
• Figure 9.11: Trends and Forecast for the South Korean Biopsy Gun Market ($M) (2019-2035)
• Figure 9.12: Trends and Forecast for the Indonesian Biopsy Gun Market ($M) (2019-2035)
• Figure 10.1: Trends and Forecast for the ROW Biopsy Gun Market (2019-2035)
• Figure 10.2: ROW Biopsy Gun Market by Type in 2019, 2025, and 2035
• Figure 10.3: Trends of the ROW Biopsy Gun Market ($M) by Type (2019-2025)
• Figure 10.4: Forecast for the ROW Biopsy Gun Market ($M) by Type (2026-2035)
• Figure 10.5: ROW Biopsy Gun Market by Application in 2019, 2025, and 2035
• Figure 10.6: Trends of the ROW Biopsy Gun Market ($M) by Application (2019-2025)
• Figure 10.7: Forecast for the ROW Biopsy Gun Market ($M) by Application (2026-2035)
• Figure 10.8: Trends and Forecast for the Middle Eastern Biopsy Gun Market ($M) (2019-2035)
• Figure 10.9: Trends and Forecast for the South American Biopsy Gun Market ($M) (2019-2035)
• Figure 10.10: Trends and Forecast for the African Biopsy Gun Market ($M) (2019-2035)
• Figure 11.1: Porter's Five Forces Analysis of the Global Biopsy Gun Market
• Figure 11.2: Market Share (%) of Top Players in the Global Biopsy Gun Market (2025)
• Figure 12.1: Growth Opportunities for the Global Biopsy Gun Market by Type
• Figure 12.2: Growth Opportunities for the Global Biopsy Gun Market by Application
• Figure 12.3: Growth Opportunities for the Global Biopsy Gun Market by Region
• Figure 12.4: Emerging Trends in the Global Biopsy Gun Market

List of Tables

• Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Biopsy Gun Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Biopsy Gun Market by Region
• Table 1.3: Global Biopsy Gun Market Parameters and Attributes
• Table 3.1: Trends of the Global Biopsy Gun Market (2019-2025)
• Table 3.2: Forecast for the Global Biopsy Gun Market (2026-2035)
• Table 4.1: Attractiveness Analysis for the Global Biopsy Gun Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Biopsy Gun Market (2019-2025)
• Table 4.3: Market Size and CAGR of Various Type in the Global Biopsy Gun Market (2026-2035)
• Table 4.4: Trends of Fully Automatic in the Global Biopsy Gun Market (2019-2025)
• Table 4.5: Forecast for Fully Automatic in the Global Biopsy Gun Market (2026-2035)
• Table 4.6: Trends of Semi-Automatic in the Global Biopsy Gun Market (2019-2025)
• Table 4.7: Forecast for Semi-Automatic in the Global Biopsy Gun Market (2026-2035)
• Table 5.1: Attractiveness Analysis for the Global Biopsy Gun Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Biopsy Gun Market (2019-2025)
• Table 5.3: Market Size and CAGR of Various Application in the Global Biopsy Gun Market (2026-2035)
• Table 5.4: Trends of Hospitals in the Global Biopsy Gun Market (2019-2025)
• Table 5.5: Forecast for Hospitals in the Global Biopsy Gun Market (2026-2035)
• Table 5.6: Trends of Clinics in the Global Biopsy Gun Market (2019-2025)
• Table 5.7: Forecast for Clinics in the Global Biopsy Gun Market (2026-2035)
• Table 5.8: Trends of Others in the Global Biopsy Gun Market (2019-2025)
• Table 5.9: Forecast for Others in the Global Biopsy Gun Market (2026-2035)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Biopsy Gun Market (2019-2025)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Biopsy Gun Market (2026-2035)
• Table 7.1: Trends of the North American Biopsy Gun Market (2019-2025)
• Table 7.2: Forecast for the North American Biopsy Gun Market (2026-2035)
• Table 7.3: Market Size and CAGR of Various Type in the North American Biopsy Gun Market (2019-2025)
• Table 7.4: Market Size and CAGR of Various Type in the North American Biopsy Gun Market (2026-2035)
• Table 7.5: Market Size and CAGR of Various Application in the North American Biopsy Gun Market (2019-2025)
• Table 7.6: Market Size and CAGR of Various Application in the North American Biopsy Gun Market (2026-2035)
• Table 7.7: Trends and Forecast for the United States Biopsy Gun Market (2019-2035)
• Table 7.8: Trends and Forecast for the Mexican Biopsy Gun Market (2019-2035)
• Table 7.9: Trends and Forecast for the Canadian Biopsy Gun Market (2019-2035)
• Table 8.1: Trends of the European Biopsy Gun Market (2019-2025)
• Table 8.2: Forecast for the European Biopsy Gun Market (2026-2035)
• Table 8.3: Market Size and CAGR of Various Type in the European Biopsy Gun Market (2019-2025)
• Table 8.4: Market Size and CAGR of Various Type in the European Biopsy Gun Market (2026-2035)
• Table 8.5: Market Size and CAGR of Various Application in the European Biopsy Gun Market (2019-2025)
• Table 8.6: Market Size and CAGR of Various Application in the European Biopsy Gun Market (2026-2035)
• Table 8.7: Trends and Forecast for the German Biopsy Gun Market (2019-2035)
• Table 8.8: Trends and Forecast for the French Biopsy Gun Market (2019-2035)
• Table 8.9: Trends and Forecast for the Spanish Biopsy Gun Market (2019-2035)
• Table 8.10: Trends and Forecast for the Italian Biopsy Gun Market (2019-2035)
• Table 8.11: Trends and Forecast for the United Kingdom Biopsy Gun Market (2019-2035)
• Table 9.1: Trends of the APAC Biopsy Gun Market (2019-2025)
• Table 9.2: Forecast for the APAC Biopsy Gun Market (2026-2035)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Biopsy Gun Market (2019-2025)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Biopsy Gun Market (2026-2035)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Biopsy Gun Market (2019-2025)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Biopsy Gun Market (2026-2035)
• Table 9.7: Trends and Forecast for the Japanese Biopsy Gun Market (2019-2035)
• Table 9.8: Trends and Forecast for the Indian Biopsy Gun Market (2019-2035)
• Table 9.9: Trends and Forecast for the Chinese Biopsy Gun Market (2019-2035)
• Table 9.10: Trends and Forecast for the South Korean Biopsy Gun Market (2019-2035)
• Table 9.11: Trends and Forecast for the Indonesian Biopsy Gun Market (2019-2035)
• Table 10.1: Trends of the ROW Biopsy Gun Market (2019-2025)
• Table 10.2: Forecast for the ROW Biopsy Gun Market (2026-2035)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Biopsy Gun Market (2019-2025)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Biopsy Gun Market (2026-2035)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Biopsy Gun Market (2019-2025)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Biopsy Gun Market (2026-2035)
• Table 10.7: Trends and Forecast for the Middle Eastern Biopsy Gun Market (2019-2035)
• Table 10.8: Trends and Forecast for the South American Biopsy Gun Market (2019-2035)
• Table 10.9: Trends and Forecast for the African Biopsy Gun Market (2019-2035)
• Table 11.1: Product Mapping of Biopsy Gun Suppliers Based on Segments
• Table 11.2: Operational Integration of Biopsy Gun Manufacturers
• Table 11.3: Rankings of Suppliers Based on Biopsy Gun Revenue
• Table 12.1: New Product Launches by Major Biopsy Gun Producers (2019-2025)
• Table 12.2: Certification Acquired by Major Competitor in the Global Biopsy Gun Market